Alexander Breidenbach
Fortune : 421 828 $ au 31/07/2026
Fortune : 421 828 $ au 31/07/2026
Alexander Breidenbach currently works at Pharming Group NV, as Chief Business Officer from 2023.
Mr. Breidenbach also formerly worked at Acm Biosciences AG, as Chief Business & Development Officer.
Mr. Breidenbach received his Masters Business Admin degree from ESSEC Business School, Masters Business Admin degree from Mannheim Business School gGmbH, and doctorate degree from The University of Veterinary Medicine Hanover.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PHARMING GROUP NV 0,06 % | 31/03/2026 | 417 482 ( 0,06 % ) | 421 828 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PHARMING GROUP N.V. | Corporate Officer/Principal | 01/09/2023 |
| Sociétés | Poste | Fin |
|---|
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Pharming Group NV
Pharming Group NV Pharmaceuticals: MajorHealth Technology Develops and commercializes protein replacement therapies and precision medicines | Health Technology |
ESSEC Business School
ESSEC Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mannheim Business School gGmbH
Mannheim Business School gGmbH Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Veterinary Medicine Hanover
The University of Veterinary Medicine Hanover Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national